Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial

INTERVENTION: Experimental group:TCM+Routine treatment of Western Medicine;Control group:Routine treatment of Western Medicine; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: Body temperature;TCM syndrome integral;Murray lung injury score;The transition time of novel coronavirus nucleic acid;MuLBSTA score; INCLUSION CRITERIA: (1) Patients in accordance with the diagnostic criteria of "Quick reference guide for diagnosis and treatment of novel coronavirus pneumonia(2019‐nCoV)(Standard Edition)" and "Diagnostic and treatment protocols of novel coronavirus pneumonia(Trial version 5)" issued by National Health Commission; (2) Patients in accordance with the TCM syndrome differentiation standard; (3) Aged 18 to 85 years; (4) Before the trial begins, patients or their legal representatives voluntarily agree to participate by giving written informed consent approved by ethic committee.